Cargando…
COVID-19, asthme sévère et biothérapies
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SPLF. Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969857/ https://www.ncbi.nlm.nih.gov/pubmed/33771438 http://dx.doi.org/10.1016/j.rmr.2021.03.002 |
| _version_ | 1783666314477305856 |
|---|---|
| author | Underner, M. Taillé, C. Peiffer, G. Perriot, J. Jaafari, N. |
| author_facet | Underner, M. Taillé, C. Peiffer, G. Perriot, J. Jaafari, N. |
| author_sort | Underner, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7969857 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SPLF. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79698572021-03-18 COVID-19, asthme sévère et biothérapies Underner, M. Taillé, C. Peiffer, G. Perriot, J. Jaafari, N. Rev Mal Respir Lettre À La Rédaction SPLF. Published by Elsevier Masson SAS. 2021-04 2021-03-18 /pmc/articles/PMC7969857/ /pubmed/33771438 http://dx.doi.org/10.1016/j.rmr.2021.03.002 Text en © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Lettre À La Rédaction Underner, M. Taillé, C. Peiffer, G. Perriot, J. Jaafari, N. COVID-19, asthme sévère et biothérapies |
| title | COVID-19, asthme sévère et biothérapies |
| title_full | COVID-19, asthme sévère et biothérapies |
| title_fullStr | COVID-19, asthme sévère et biothérapies |
| title_full_unstemmed | COVID-19, asthme sévère et biothérapies |
| title_short | COVID-19, asthme sévère et biothérapies |
| title_sort | covid-19, asthme sévère et biothérapies |
| topic | Lettre À La Rédaction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969857/ https://www.ncbi.nlm.nih.gov/pubmed/33771438 http://dx.doi.org/10.1016/j.rmr.2021.03.002 |
| work_keys_str_mv | AT undernerm covid19asthmesevereetbiotherapies AT taillec covid19asthmesevereetbiotherapies AT peifferg covid19asthmesevereetbiotherapies AT perriotj covid19asthmesevereetbiotherapies AT jaafarin covid19asthmesevereetbiotherapies |